open access

Vol 18, No 6 (2011)
Technology notes
Published online: 2011-11-23
Submitted: 2013-01-14
Get Citation

New developments in the treatment of severe drug resistant hypertension

S. Suave Lobodzinski
Cardiol J 2011;18(6):707-711.

open access

Vol 18, No 6 (2011)
Technology notes
Published online: 2011-11-23
Submitted: 2013-01-14

Abstract

The purpose of this paper is to review the state-of-the-art of renal denervation system technology for treatment of drug resistant hypertension. We describe an investigational device that is currently tested in an on-going clinical trial. The denervation device uses the RF thermal ablation catheter attached to the RF generator. The RF catheter is inserted into the renal artery and positioned in the vicinity of the efferent and afferent parasympathetic innervations. Renal denervation is a minimally invasive, localized procedure and the procedural and recovery times are very short. The entire procedure lasts about 40 min. In early clinical trials, the systolic blood pressure in 87% of patients who underwent the denervation procedure resulted in an average blood pressure drop of greater than 10 mm Hg. The procedure has no systematic side effects, and appears to be beneficial in the management of hypertension in patients refractory to pharmacological therapy. (Cardiol J 2011; 18, 6: 707–711)

Abstract

The purpose of this paper is to review the state-of-the-art of renal denervation system technology for treatment of drug resistant hypertension. We describe an investigational device that is currently tested in an on-going clinical trial. The denervation device uses the RF thermal ablation catheter attached to the RF generator. The RF catheter is inserted into the renal artery and positioned in the vicinity of the efferent and afferent parasympathetic innervations. Renal denervation is a minimally invasive, localized procedure and the procedural and recovery times are very short. The entire procedure lasts about 40 min. In early clinical trials, the systolic blood pressure in 87% of patients who underwent the denervation procedure resulted in an average blood pressure drop of greater than 10 mm Hg. The procedure has no systematic side effects, and appears to be beneficial in the management of hypertension in patients refractory to pharmacological therapy. (Cardiol J 2011; 18, 6: 707–711)
Get Citation

Keywords

hypertension; renal denervation; RF ablation

About this article
Title

New developments in the treatment of severe drug resistant hypertension

Journal

Cardiology Journal

Issue

Vol 18, No 6 (2011)

Pages

707-711

Published online

2011-11-23

Bibliographic record

Cardiol J 2011;18(6):707-711.

Keywords

hypertension
renal denervation
RF ablation

Authors

S. Suave Lobodzinski

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl